RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s clinical programs at the following investor conferences:
Cowen & Co. 32nd Annual Healthcare Conference in Boston, Massachusetts on Monday, March 5, 2012 at 4:50 p.m. Eastern time
